Check our
Open Access Repository.
2020
348 publication(s):Note: when necessary, only the first 5 authors are displayed.Articles
- 171 -
-
Dynamics of the Transcriptional Landscape During Human Fetal Testis and Ovary Development
- Estelle Lecluze, Antoine D. Rolland, Panagiotis Filis, Bertrand Evrard, Sabrina Leverrier-Penna et al.
- Human Reproduction, 2020, 35 (5), pp.1099-1119.
- DOI : https://doi.org/10.1093/humrep/deaa041
- Pubmed : 32412604
-
-
- 172 -
-
Comparative study on gene expression profile in rat lung after repeated exposure to diesel and biodiesel exhausts upstream and downstream of a particle filter
- Valérie Lecureur, Christelle Monteil, Marie Jaguin, Fabrice Cazier, David Préterre et al.
- Environmental Pollution, 2020, 266 (Part 2), pp.115264.
- DOI : https://doi.org/10.1016/j.envpol.2020.115264
- Pubmed : 32771839
-
-
- 173 -
-
Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments
- Florian Lemaitre, Caroline Solas, Matthieu Grégoire, Laurence Lagarce, Laure Elens et al.
- Fundamental & Clinical Pharmacology, 2020, 34 (5), pp.530-547.
- DOI : https://doi.org/10.1111/fcp.12586
- Pubmed : 32603486
-
-
- 174 -
-
Synthèse des recommandations de l’International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) sur le suivi thérapeutique pharmacologique du tacrolimus
Summary of the recommendations of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) on the therapeutic drug monitoring of tacrolimus
- F. Lemaître, C. Monchaud, J.-B. Woillard, N. Picard, Philippe Marquet et al.
- Synthèse des recommandations de l’International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) sur le suivi thérapeutique pharmacologique du tacrolimus. Therapies, 2020, 75 (6), pp.681-685.
- DOI : https://doi.org/10.1016/j.therap.2020.06.004
- Pubmed : 32653093
-
-
- 175 -
-
Affections non-directement attribuables à la sclérodermie systémique (ANDAS) diagnostiquées au cours du suivi dans un centre de compétence: à propos d'une cohorte de 200 patients
- C Lepart, S Ardois, M Bismut, A Ballerie, C Cazalets et al.
- La Revue de Médecine Interne, 2020, 41 (8), pp.517-522.
- DOI : https://doi.org/10.1016/j.revmed.2020.03.001
- Pubmed : 32354573
-
-
- 176 -
-
IMPACT OF JAK INHIBITORS ON MACROPHAGE POLARISATION: PERSPECTIVES FOR SYSTEMIC SCLEROSIS
- A. Lescoat, A. Ballerie, M. Lelong, Claudie Morzadec, Stéphane Jouneau et al.
- Annals of the Rheumatic Diseases, 2020, 79 (Suppl 1), pp.1376-1376.
- DOI : https://doi.org/10.1136/annrheumdis-2020-eular.5528
-
-
- 177 -
-
Crystalline Silica Impairs Efferocytosis Abilities of Human and Mouse Macrophages: Implication for Silica-Associated Systemic Sclerosis
- Alain Lescoat, Alice Ballerie, Marie Lelong, Yu Augagneur, Claudie Morzadec et al.
- Frontiers in Immunology, 2020, 11, pp.219.
- DOI : https://doi.org/10.3389/fimmu.2020.00219
- Pubmed : 32133004
-
-
- 178 -
-
The neglected association of crystalline silica exposure and systemic sclerosis
- Alain Lescoat, Alice Ballerie, Valérie Lecureur, Nicolas Belhomme, Claire Cazalets et al.
- Rheumatology, 2020, 12 (59), pp.3587-3588.
- DOI : https://doi.org/10.1093/rheumatology/keaa638
- Pubmed : 33020830
-
-
- 179 -
-
Silica Exposure and Scleroderma: More Bridges and Collaboration Between Disciplines Are Needed
- Alain Lescoat, Catherine Cavalin, Alice Ballerie, Valérie Lecureur, Lucile Sesé et al.
- American Journal of Respiratory and Critical Care Medicine, 2020, 201 (7), pp.880-882.
- DOI : https://doi.org/10.1164/rccm.201911-2218LE
- Pubmed : 31881815
-
-
- 180 -
-
Combined anti-fibrotic and anti-inflammatory properties of JAK-inhibitors on macrophages in vitro and in vivo perspectives for scleroderma-associated interstitial lung disease
- Alain Lescoat, Marie Lelong, Mohamed Jeljeli, Claire Piquet-Pellorce, Claudie Morzadec et al.
- Biochemical Pharmacology, 2020, 178, pp.114103.
- DOI : https://doi.org/10.1016/j.bcp.2020.114103
- Pubmed : 32562787
-
-